Meeting
2024 ASCO Quality Care Symposium
A prospective, longitudinal study of health-related quality of life and contributing factors and its impact on medication adherence to oral anticancer agents in real-world patients with leukemia.
Presenter
Benyam Muluneh, PharmD
Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Videos & Slides Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Quality, Safety, and Implementation Science,Cost, Value, and Policy,Patient Experience,Palliative and Supportive Care
Sub Track
Symptom Prevention, Assessment, and Management
Citation
JCO Oncol Pract 20, 2024 (suppl 10; abstr 270)
DOI
10.1200/OP.2024.20.10_suppl.270
Abstract #
270
Poster Bd #
E15
Abstract Disclosures
Similar Videos & Slides
Videos & Slides
2024 ASCO Quality Care Symposium
Evaluating enrollment processes and eligibility criteria of manufacturer free-drug patient assistance programs for oral anticancer agents used in hematologic malignancies.
Speaker: Benyam Muluneh, PharmD
Videos & Slides
2024 ASCO Breakthrough
Identifying risk factors associated with self-reported lower quality of life (QoL) in individuals with PTEN hamartoma tumor syndrome.
Speaker: Terralyn Schmidt, LCGC
Videos & Slides
2024 ASCO Annual Meeting
Randomized trial of a multimodal intervention to enhance sexual function and quality of life (QOL) in hematopoietic stem cell transplant (HSCT) survivors.
Speaker: Areej El-Jawahri, MD
Videos & Slides
2024 ASCO Annual Meeting
Health-related quality of life (QoL) in randomized phase III trials in oncology: Association between results of QoL, results of primary endpoint and drug approval.
Speaker: Massimo Di Maio, MD